More Related Content
What's hot
What's hot (20)
Similar to Continua Health Alliance
Similar to Continua Health Alliance (20)
More from Iiro Jantunen
More from Iiro Jantunen (18)
Recently uploaded
Recently uploaded (20)
Continua Health Alliance
- 1. Continua Health Alliance “ Strategic Intelligence Monitor on Personal Health Systems” Workshop – IPTS, EC April 2009 Mario Romao Co-Chair, EU Policy WG, Continua Health Alliance Senior Manager, Healthcare Policy, Intel Corporation Extended team: Stelios Tsintzos, Medtronic; Brigitte Piniewski, Oregon Medical Laboratories; Luis Perez, Telefonica; Christine Claus, Intel; Petra Wilson, Cisco; Vesa Pakarinen, VTT; Charles Lowe, Telehealth Solutions; Chuck Parker, Continua Health Alliance
- 2. The Continua Health Alliance Mission
- 4. Promoter Members Open International
- 6. Guidelines Certification Recognizable Logo
- 7. Version One Design Guidelines 06/24/09 After two years of work from more than 175 companies around the world, Continua Health Alliance is proud to announce the formal release of its Version One Design Guidelines and the Continua Certification Program Continua Version One Guidelines
- 8. 1 st Continua Certified Product Congratulations to Nonin Medical, Inc.!
- 10. Version One Health Record Standards Home-based Remote Patient Monitoring (RPM) System Vital Sign Devices Patient Electronic Health Record System EHR / PHR Labs Healthcare Provider Disease Management Service XDR Transport Specification CDA/CCD-based Personal Health Monitoring (PHM) Specification
- 11. First Public Interoperability Demonstration Harvard Medical Auditorium 10/27/08 Weighing Scale Wireless Pulse Oximeter Blood Pressure Monitor Device Interface XHR Interface EHR Heart Failure & COPD EHR PHR Telehealth Service Telehealth Service Telehealth Service Obesity & Diabetes
- 13. Working Group Structure Over 1,400 members participating in the various Working Groups Board Of Directors Use Case WG Technical WG Test & Certification WG Employer HR Benefits WG VTM Administration Expert Group NHS, AAFP, ATA, AHA… Sub- Committees PR & Marketing agency Marketing WG Regulatory WG Policy Strategy WG Australia Policy WG EU Policy WG Japan Policy WG Latin America Policy WG U.S. Policy WG U.S. Payer WG Executive Director
- 14. PHS market now and in the future: enablers and drivers
- 20. PHS market in the future: the continuum of life and care Amateur Athlete Diet/Fitness Focused Worried Well Elderly Living Independently Chronic Patient Acute Recovery Infant CONTINUUM of LIFE CONTINUUM of CARE GIVERS Doctor/NP/Nurse Home Nursing Professional The Family Fitness Wellness Coach New Parents The Continua Health Alliance “connected health and care” vision blurs the frontiers across solutions for healthcare, wellness and ageing independently. The individual truly becomes the hub for wellness and health management.
- 22. PHS market in the future: disease management The Innovative Care for Chronic Conditions Framework (WHO)
- 25. Weight Scale Person Centered Device / Systems / Sensors Biometrics Testing HRA/Health Administrative Assistant Classes Information Systems Fitness Equipment Wellness Management/Support Systems Blood-Presser Cuff Glucose Meter Spirometer Pulse Oximeter Medication Tracking Pedometer Cholesterol HDL/LDL Weight Blood-Pressure Blood Sugar Resting Heart Rate Lung Air Volume Triglycerides Body Fat % Body Fat Analyzer Bio-metric/ Behavioral Responses Multiple providers / service oriented Wellness Center PHR/PHA Fitness, nutrition, stress management… PHS market in the future: the coalescence of market segments Activity Hub Family care givers Elderly monitoring services Disease managementservice Healthcareprovider Gait analysis
- 28. Thank You Thank you! [email_address] www.continuaalliance.org
Editor's Notes
- A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
- A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
- A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
- A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.